missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Gibco™ Mouse G-CSF Recombinant Protein, PeproTech®
E. coli Recombinant Protein
89.25 CHF - 4330.00 CHF
Spezifikation
Zugriffsnummer | P09920 |
---|---|
Zur Verwendung mit (Anwendung) | ELISA, Functional Assay, Western Blot |
Zusammensetzung | protein with no preservative |
Gen-ID (Entrez) | 12985 |
Molekulargewicht | 19 |
Produktcode | Marke | Menge | Preis | Menge & Verfügbarkeit | |||||
---|---|---|---|---|---|---|---|---|---|
Produktcode | Marke | Menge | Preis | Menge & Verfügbarkeit | |||||
17840033
|
Gibco™
250-05-100UG |
100 μg |
868.00 CHF
100 Mikrogramm |
Verfügbar ab: 04-12-2024
Loggen Sie sich ein, um den Lagerbestand zu sehen |
|||||
17870413
|
Gibco™
250-05-10UG |
10 μg |
217.00 CHF
10 Mikrogramm |
Lager vorrätigLoggen Sie sich ein, um den Lagerbestand zu sehen
|
|||||
17841283
|
Gibco™
250-05-1MG |
1 mg |
4330.00 CHF
1 Milligramm |
Verfügbar ab: 04-12-2024
Loggen Sie sich ein, um den Lagerbestand zu sehen |
|||||
17860713
|
Gibco™
250-05-250UG |
250 μg |
1518.00 CHF
250 Mikrogramm |
Verfügbar ab: 04-12-2024
Loggen Sie sich ein, um den Lagerbestand zu sehen |
|||||
17870203
|
Gibco™
250-05-2UG |
2 μg |
89.25 CHF
2 Mikrogramm |
Lager vorrätigLoggen Sie sich ein, um den Lagerbestand zu sehen
|
|||||
17840383
|
Gibco™
250-05-500UG |
500 μg |
2600.00 CHF
500 Mikrogramm |
Verfügbar ab: 04-12-2024
Loggen Sie sich ein, um den Lagerbestand zu sehen |
|||||
17851573
|
Gibco™
250-05-50UG |
50 μg |
522.00 CHF
50 Mikrogramm |
Lager vorrätigLoggen Sie sich ein, um den Lagerbestand zu sehen
|
|||||
Beschreibung
G-CSF (Granulocyte colony stimulating factor) is a naturally occurring cytokine that stimulates the production and antibacterial function of neutrophils and monocytes. Human G-CSF is an 18.8 kDa protein containing 175 amino acid residues, and a soluble isoform of the G-CSF receptor has been described. The pleotropic cytokine is produced by activated monocytes, macrophages, endothelial cells, fibroblasts, astrocytes, osteoblasts and bone marrow cells. G-CSF has been shown to have specific effects on the proliferation, differentiation and activation of hematopoietic cells. G-CSF is also expressed by various transformed cells such as carcinoma cells and myeloblastic leukemia cells. G-CSF is encoded by two distinct DNA sequences, resulting in a full size, high activity and a shorter, low activity isoform of G-CSF. G-CSF is highly conserved among species and has been shown to exert its biological functions through interaction with its receptor expressed on the surface of hematopoietic progenitors, neutrophilic granulocytes and certain carcinoma cell lines. Clinical use of G-CSF has been approved for several therapeutic applications, treatment of neonatal infections, therapy of acute myocardial infarction, granulocyte transfusion in patients with neutropenia, in severe infections and sepsis, therapy in chronic autoimmune neutropenia, treatment of acute myeloid leukemias, Sweet's syndrome and AIDS. Further, G-CSF has been shown to be a marker protein for different carcinomas such as bladder cancer and dysfunction of the protein has been linked to Kostmann Syndrome.Spezifikation
P09920 | |
protein with no preservative | |
19 | |
E. coli | |
RUO | |
C17orf33; colony stimulating factor 3; colony stimulating factor 3 (granulocyte); CSF 3; CSF3; CSF3OS; Csfg; filgrastim; GCSF; G-CSF; Granulocyte colony-stimulating factor; granulocyte-colony stimulating factor; gsf3; lenograstim; MGC45931; MGI-IG; Pluripoietin; RP23-395E10.4 | |
Mouse | |
Recombinant | |
Lyophilized |
ELISA, Functional Assay, Western Blot | |
12985 | |
Mouse G-CSF | |
-20°C | |
<1 EU/μg | |
Csf3 | |
Unconjugated | |
MVPLVTVSAL PPSLPLPRSF LLKSLEQVRK IQASGSVLLE QLCATYKLCH PEELVLLGHS LGIPKASLSG CSSQALQQTQ CLSQLHSGLC LYQGLLQALS GISPALAPTL DLLQLDVANF ATTIWQQMEN LGVAPTVQPT QSAMPAFTSA FQRRAGGVLA ISYLQGFLET ARLALHHLA | |
≥ 98% by SDS-PAGE gel and HPLC analyses. |